Pediatric Drug Development - Visionary Promise Or Nightmare?

SAPhS PharmaLunch
Basel, January 26, 2018

Klaus Rose, M.D., M.S., klausrose Consulting, Pediatric Drug Development & More

- Chronological age, physiology, and why children are not "therapeutic orphans"
- Medical sense in FDA/EMA-demanded pediatric studies?
- Largest systematic abuse of patients in clinical research in history?
- Challenges for clinical community, media, lawyers, Ethics Committees/IRBs
- Ways forward

Logo of Swiss Academy of Pharmaceutical Sciences